Compass helps biotech and pharma organizations staff high-performing regulatory affairs teams that navigate evolving FDA expectations and keep programs moving.
Our niche life sciences focus and consultative approach mean you get talent that fits your culture and is delivered by professionals who speak your language and adapt to your goals.
Compass professionals ensure accuracy and speed across IND, NDA, BLA, and global filings. From CTD/eCTD publishing to labeling and promotional review, we maintain compliance and inspection readiness at every step.
We connect technical and regulatory teams to support CMC strategy, Module 3 authoring, and post-approval changes. Our specialists help sustain compliance and product continuity throughout the lifecycle.
Our experts guide programs from pre-IND through post-market, aligning regulatory goals with science and business needs. We streamline submissions, manage agency interactions, and anticipate evolving requirements to keep development moving.
Compass partners with life sciences companies from idea to approval, aligning regulatory expertise with scientific and business goals. Our industry-native team adapts to the pace of startups through established pharma.
We help:
From Associate to Chief Regulatory Officer (CRO)—and every level in between.
A rapidly growing biotech needed specialized regulatory talent to advance its IND-enabling studies on an aggressive timeline.
Compass quickly placed experienced experts who strengthened IND preparation, improved cross-functional alignment, and kept milestones on track.
Result: The company advanced toward first-in-human trials with stronger regulatory readiness and execution discipline.
We deliver talent and strategic solutions across every phase of the life sciences asset development—from R&D to Commercialization.
